Piribedil
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 10% (peak at 1 hour) |
Protein binding | 70–80% |
Metabolism | extensive liver |
Elimination half-life | 1.7–6.9 hours |
Excretion | Kidney (68%) and bile duct (25%) |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Piribedil (trade names Pronoran, Trivastal Retard, Trastal, Trivastan, Clarium and others) is an
Medical uses
- Treatment of levodopa) or in combination with L-DOPA therapy, in the early stages of the disease as well as in the advanced ones
- Treatment of , etc.)
- Treatment of dizziness in the young patients
- Treatment of ischemicmanifestations
- Adjunctive treatment of lower limbs(stage 2)
- Adjunctive treatment of off label)
- Treatment of gait disorders associated with Parkinson's disease (no related cause) and other forms of parkinsonism
Other uses
The drug has been shown to enhance working memory capacities in normal aging adults.[4]
In age-related memory impairment, it has a positive effect on psychophysiological state of elderly people, improving memory and attention and increasing the velocity of psychomotor reactions and lability of nervous processes.[5]
It enhances cognitive skill learning in healthy older adults.[6]
It showed a positive effect in restless legs syndrome.[7]
Side effects
- Minor gastrointestinal upset (nausea, vomiting, flatulence, etc.) in predisposed individuals, or when taken between meals: adjust dosage individually, and/or add domperidone;
- drowsinessmay occur, particularly in predisposed individuals (underlying condition or causative illness);
- Mild dizziness, confusion and feeling "drunk" also may occur.
As with other dopamine agonists (like
Another rare side effect of piribedil is excessive daytime sleepiness and unintended sleep episodes.[9][10]
Overdose
At very high doses, piribedil has an emetic action on the chemoreceptor trigger zone (CTZ). Tablets will thus be rapidly rejected, which explains why no data are currently available concerning the risk of overdosage.[medical citation needed]
Interactions
Dopamine antagonists reduce the effect of piribedil.[medical citation needed]
Pharmacology
Pharmacodynamics
- Dopamine receptor agonist, selective for subtypes D2 and D3.
- Dopamine receptor antagonist, selective for subtypes D4.[11][12][13]
- Adrenergic receptor antagonist, subtypes α2A and α2C.[14]
- Lack of affinity to serotonin receptor 5-HT2B.[14]
References
- ^ "Active substance: piribedil" (PDF). List of nationally authorised medicinal products. European Medicines Agency. 26 November 2020.
- PMID 11356907.
- S2CID 29234876.
- S2CID 792757.
- PMID 15792142.
- S2CID 24952829.
- S2CID 39995329.
- S2CID 30844295.
- ^ a b TRIVASTAL Retard 50 (piribedil) Prescribing Information, Servier Laboratories, April 2008. [1] Archived 19 December 2012 at the Wayback Machine
- S2CID 22169346.
- S2CID 16143246.
- PMID 11532743.
- S2CID 35238120.
- ^ a b Schubert-Zsilavecz M. "Piribedil". Neue Arzneimittel 2008 (in German).